Trending Now
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) Granted Orphan Drug Designation For...
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) has announced that the FDA has granted TNX-2900 an Orphan Drug Designation for Prader-Willi syndrome treatment.
Tonix receives Orphan...
1606 Corp (CBDW) Expands into Artificial Intelligence with the Introduction of...
The realm of artificial intelligence has been present for a while, yet it garnered heightened attention with the launch of ChatGPT and...
1606 Corp ($CBDW) Preps for Global Launch of Cutting-Edge ChatCBD AI-Driven...
1606 Corp. (OTC Pink: CBDW) is gearing up for the global launch of ChatCBD, an advanced AI-driven online merchandising technology set to debut...
Popular News
Atara Biotherapeutics Inc. (NASDAQ:ATRA) Presents Positive ATA188 Study Data Showing Safety...
Atara Biotherapeutics Inc. (NASDAQ:ATRA) has announced the release of efficacy and safety data of its First Phase ATA 188 study in progressive forms of...
MAKE IT MODERN
LATEST REVIEWS
Tongji Healthcare Group Inc (OTCMKTS:TONJ) Closes Clubhouse Acquisition Becoming Dominant Social...
Tongji Healthcare Group Inc (OTCMKTS:TONJ) is as interesting a story on the OTC right as one might hope to find. The social media influencer...
MAKE IT MODERN
PERFORMANCE TRAINING
Celldex Therapeutics Inc. (NASDAQ:CLDX) Announce Encouraging CDX-0159 Study Results In Reducing Plasma Tryptase
Celldex Therapeutics Inc. (NASDAQ:CLDX) has announced results from its first phase, double-blind, randomized, placebo-controlled, dose-escalation KIT inhibitor CDX-0159 study in healthy subjects.
CDX-0159 shows a...
Light Bio Inc and Gingko Bioworks Holdings Inc (NYSE: DNA) Announce Their Recent Partnership...
Light Bio Inc recently announced the execution of a partnership with Ginkgo Bioworks Holdings Inc (NYSE: DNA) to create specific cell assays for bioluminescence...
Denali Therapeutics Inc (NASDAQ:DNLI) Releases Major Update On Phase 1b Of Its RIPK1 Program
Denali Therapeutics Inc (NASDAQ:DNLI) provided an update on Phase 1b trial findings involving its RIPK1 small molecule inhibitor used to target ALS and Alzheimer’s...
1606 Corp (CBDW) Expands into Artificial Intelligence with the Introduction of CHATCBDW
The realm of artificial intelligence has been present for a while, yet it garnered heightened attention with the launch of ChatGPT and...
Affimed NV (NASDAQ:AFMD) Administers AFM13 Dose To The First Phase 1 Clinical Trial Patient
Affimed NV (NASDAQ:AFMD) kicked off October on a strong note particularly with the launch of its Phase 1 Clinical of its pipeline cancer therapy...